CLINICAL AND BIOCHEMICAL PREDICTORS OF [18F]PSMA-1007 PET IMAGING OF PROSTATE CANCER AT STAGING AND BIOCHEMICAL RECURRENCE

被引:0
|
作者
Chikatamarla, A. [1 ,2 ]
Okano, S. [3 ]
Ansaldo, A. [1 ]
Jenvey, P. [1 ]
Thomas, P. [1 ]
Ramsay, S. [1 ]
Roberts, M. [1 ,2 ]
Pattison, D. [1 ]
机构
[1] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[2] Univ Queensland, Brisbane, Qld, Australia
[3] QIMR, Brisbane, Qld, Australia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
O21
引用
收藏
页码:12 / 12
页数:1
相关论文
共 50 条
  • [41] Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
    Tragardh, Elin
    Minarik, David
    Brolin, Gustav
    Bitzen, Ulrika
    Olsson, Bent
    Oddstig, Jenny
    EJNMMI PHYSICS, 2020, 7 (01)
  • [42] Dose Reduced [18F]PSMA-1007 PET is Feasible for Functional Imaging of the Renal Cortex
    Valind, K.
    Brolin, G.
    Jogi, J.
    Minarik, D.
    Tragardh, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S339 - S340
  • [43] Evaluation of 18F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
    Zhou, Xing
    Jiang, Xiao
    Liu, Luzhou
    Wang, Xiaoxiong
    Li, Chuan
    Yao, Yutang
    Kou, Ying
    Shen, Jiaqi
    Shen, Taipeng
    Li, Zeng
    Yang, Shengke
    Zhou, Shukui
    Liao, Hong
    Luo, Zhifu
    Wu, Xiaoai
    Chen, Shirong
    Cheng, Zhuzhong
    TRANSLATIONAL ONCOLOGY, 2022, 15 (01):
  • [44] Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging in prostate cancer with extended lymph node dissection as reference method
    Hvittfeldt, E.
    Ingvar, J.
    Tragardh, E.
    Simoulis, A.
    Bjartell, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S482 - S482
  • [45] Diagnostic accuracy and therapeutic impact of [18F] DCFPyL (PSMA) PET/CT in biochemical recurrence of prostate cancer
    Fernandez, J. Fernandez
    Ibanez, E. Trivino
    Solero, T. Rudolphi
    Navas, D. Rivas
    Fernandez, A. Rodriguez
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S291 - S291
  • [46] PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h
    Hvittfeldt, Erland
    Bitzen, Ulrika
    Minarik, David
    Oddstig, Jenny
    Olsson, Berit
    Tragardh, Elin
    EUROPEAN JOURNAL OF HYBRID IMAGING, 2023, 7 (01):
  • [47] PET/CT imaging 2 h after injection of [18F]PSMA-1007 can lead to higher staging of prostate cancer than imaging after 1 h
    Erland Hvittfeldt
    Ulrika Bitzén
    David Minarik
    Jenny Oddstig
    Berit Olsson
    Elin Trägårdh
    European Journal of Hybrid Imaging, 7
  • [48] Biokinetics and radiation dosimetry of [18F]-PSMA-1007
    Hvittfeldt, E.
    Bjoersdorff, M.
    Oddstig, J.
    Svegborn, S. Leide
    Brolin, G.
    Minarik, D.
    Tragardh, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S137 - S137
  • [49] Assessment of urinary bladder activity and detection of local prostate cancer lesions in [18F]PSMA-1007 PET/CT
    Krieger, K.
    Afshar-Oromieh, A.
    Rominger, A. O.
    Alberts, I. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S484 - S485
  • [50] The cause of high [18F]PSMA-1007 uptake in the urinary bladder in some of the [18F]PSMA-1007 patients: an explorative, retrospective study
    Allach, Y.
    Prive, B.
    van Gemert, W.
    Schilham, M.
    Perk, L. R.
    Gotthardt, M.
    Nagarajah, J.
    Janssen, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S530 - S530